facial nerve disease: A disease involving the facial nerve.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1070 |
4. Check minimum number of eventsNone |
1070 |
5. Include endpointsNone |
1070 |
6. Filter based on genotype QC (FinnGen only) |
1070 |
Control definitions (FinnGen only)
- Control exclude
- G6_NERPLEX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G50-G59
- Name in latin
- Morbositates nervi facialis
Similar endpoints
↥List of similar endpoints to
Other facial nerve disorders
based on the number of shared cases.
Similar with more cases:
- Nerve, nerve root and plexus disorders
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7545 | 4598 | 2892 |
| Only index persons | 6698 | 4159 | 2539 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.13 | 0.08 |
| Only index persons | 0.13 | 0.15 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 54.85 | 55.37 | 53.90 |
| Only index persons | 53.10 | 53.57 | 52.33 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1070 | 712 | 358 |
| Unadjusted period prevalence (%) | 0.21 | 0.24 | 0.16 |
| Median age at first event (years) | 53.22 | 52.46 | 54.74 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 954
- Matched controls
- 9540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G51.3
ICD-10 Finland
Clonic hemifacial spasm
+∞
323.0
369
*
G51.9
ICD-10 Finland
Disorder of facial nerve, unspecified
2789.7
218.3
203
*
G51.0
ICD-10 Finland
Bell palsy
331.7
212.5
208
8
G51.4
ICD-10 Finland
Facial myokymia
455.5
192.2
186
5
G51.8
ICD-10 Finland
Other disorders of facial nerve
1002.9
94.6
91
*
N03AE01
ATC
clonazepam; systemic
10.3
89.2
187
221
G24.5
ICD-10 Finland
Blepharospasm
186.3
82.6
85
5
3AX01
NOMESCO Finland
NA
206.1
74.3
76
*
ZX114
NOMESCO Finland
Intramuscular
30.3
71.3
96
35
G56.0
ICD-10 Finland
Carpal tunnel syndrome
14.1
58.9
103
81
G51.1
ICD-10 Finland
Geniculate ganglionitis
+∞
54.7
52
*
3519X
ICD-9 Finland
Facial nerve disorders, Facial nerve disorder, unspecified
+∞
48.3
46
*
G51.2
ICD-10 Finland
Melkersson syndrome
+∞
43.0
41
*
G50.1
ICD-10 Finland
Atypical facial pain
28.9
38.5
52
19
ACC51
NOMESCO Finland
Release of median nerve
139.0
38.0
40
*
N03AX12
ATC
gabapentin; oral
3.5
36.3
193
647
AAH60
NOMESCO Finland
Microvascular decompression of cranial nerve
+∞
34.6
33
*
G51
ICD-10 Finland
Facial nerve disorders
+∞
32.5
31
*
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
45.0
32.0
39
9
N03AX16
ATC
pregabalin; oral
2.7
31.0
251
1107
G50.0
ICD-10 Finland
Trigeminal neuralgia
30.5
30.9
41
14
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
10.9
29.1
56
54
N02AX02
ATC
tramadol; systemic, rectal
2.1
25.9
412
2504
R51.80
ICD-10 Finland
Headache
2.9
25.9
180
712
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
25.7
114
325
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
29.3
25.5
34
12
N06AX21
ATC
duloxetine; oral
3.3
25.4
137
457
3518X
ICD-9 Finland
Facial nerve disorders, Other facial nerve disorders
+∞
24.1
23
*
R51.81
ICD-10 Finland
Facial pain NOS
9.3
23.0
48
54
H02AB06
ATC
prednisolone; systemic
2.0
22.9
461
3042
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
21.2
417
2697
G54.0
ICD-10 Finland
Brachial plexus disorders
24.9
20.9
29
12
TAB00
NOMESCO Finland
Lumbar puncture
4.6
20.5
73
169
G44.2
ICD-10 Finland
Tension-type headache
2.7
20.2
155
645
R20.2
ICD-10 Finland
Paraesthesia of skin
3.9
20.2
87
241
G24.3
ICD-10 Finland
Spasmodic torticollis
12.5
19.2
34
28
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
+∞
18.8
18
*
N03AF01
ATC
carbamazepine; oral, rectal
4.3
18.5
71
177
H02.2
ICD-10 Finland
Lagophthalmos
33.6
18.0
23
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
17.4
348
2223
G24.8
ICD-10 Finland
Other dystonia
28.1
16.5
22
8
N02BE01
ATC
paracetamol; systemic, rectal
2.1
16.4
807
6921
M01AH05
ATC
etoricoxib; oral
1.8
16.0
551
4163
N06AX16
ATC
venlafaxine; oral
2.4
15.9
153
716
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
+∞
15.7
15
*
G56.2
ICD-10 Finland
Lesion of ulnar nerve
26.8
15.6
21
8
M03BX02
ATC
tizanidine; oral
1.8
15.4
585
4532
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
15.3
115
471
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
29.1
15.2
20
7
M01AC06
ATC
meloxicam; systemic, rectal
1.8
15.0
342
2253
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.4
14.9
133
599
M54.5
ICD-10 Finland
Low back pain
1.8
14.9
310
1981
J01DB01
ATC
cefalexin; oral
1.9
14.6
759
6438
A02BC05
ATC
esomeprazole; systemic
1.8
14.5
382
2630
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
14.1
150
733
AA1AD
NOMESCO Finland
CT of head and brain
2.0
14.0
216
1235
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
13.9
96
374
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
16.5
13.5
21
13
N06AA09
ATC
amitriptyline; systemic
2.5
13.5
109
463
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
13.3
412
2953
M03BX01
ATC
baclofen; systemic
7.3
12.8
30
42
H04.10
ICD-10 Finland
Dry eye syndrome
2.4
12.8
111
491
R42
ICD-10 Finland
Dizziness and giddiness
1.9
12.8
208
1208
G47.3
ICD-10 Finland
Sleep apnoea
2.0
12.8
188
1055
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
12.7
156
814
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
12.7
428
3130
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
4.0
12.6
50
130
G24.4
ICD-10 Finland
Idiopathic orofacial dystonia
131.6
12.5
13
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.4
12.3
109
488
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
12.2
215
1286
H02.4
ICD-10 Finland
Ptosis of eyelid
4.6
11.9
41
93
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
11.7
203
1207
A02BC03
ATC
lansoprazole; oral
1.8
11.6
264
1711
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
11.4
109
505
N03AF02
ATC
oxcarbazepine; oral
4.3
11.2
41
99
K07.60
ICD-10 Finland
Snapping jaw
3.2
11.1
59
195
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
11.1
257
1673
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
10.9
363
2616
N06AX11
ATC
mirtazapine; oral
1.7
10.8
288
1949
J01DA01
ATC
[U] cefalexin; systemic
1.6
10.8
576
4667
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.5
10.7
82
340
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.7
190
1131
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.9
10.7
43
114
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
10.7
384
2815
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.3
10.7
103
482
TQA05
NOMESCO Finland
Puncture of skin of head or neck
111.2
10.4
11
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
10.4
228
1453
XA402
NOMESCO Finland
ENMG
5.9
10.3
28
49
M25.5
ICD-10 Finland
Pain in joint
1.7
10.3
253
1670
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.8
10.3
196
1195
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.0
10.1
135
724
M01AE02
ATC
naproxen; oral, rectal
1.6
10.1
506
4011
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
9.9
454
3517
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.9
9.8
61
223
R01AD09
ATC
mometasone; nasal
1.6
9.8
400
3010
A02BC02
ATC
pantoprazole; systemic
1.5
9.7
576
4731
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
13.5
9.7
16
12
M79.6
ICD-10 Finland
Pain in limb
1.6
9.6
308
2178
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
9.5
138
763
M47.9
ICD-10 Finland
Spondylosis, unspecified
4.6
9.5
32
72
SPAT1263
SPAT
Sampling
1.6
9.5
361
2666
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
9.4
67
267
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.1
9.4
35
87
G24.9
ICD-10 Finland
Dystonia, unspecified
30.3
9.4
12
*
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
+∞
9.4
9
*
WX110
NOMESCO Finland
Local anesthesy
1.5
9.4
602
5016
ZXA00
NOMESCO Finland
Right side
1.7
9.2
229
1508
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
9.2
83
375
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.2
9.1
47
153
M01AB05
ATC
diclofenac; systemic, rectal
1.5
9.1
589
4900
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
9.0
85
393
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.9
9.0
56
204
J02AC01
ATC
fluconazole; systemic
1.5
9.0
374
2808
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
9.0
232
1546
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.0
8.8
123
671
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
8.8
333
2443
J01FA06
ATC
roxithromycin; oral
1.5
8.6
364
2738
N03AX11
ATC
topiramate; oral
3.7
8.6
36
100
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.1
8.5
95
473
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.3
8.5
77
350
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
8.5
284
2018
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
8.5
475
3797
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.1
8.5
103
531
M03AX01
ATC
botulinum toxin; parenteral
6.1
8.5
22
37
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.7
8.5
23
41
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.9
8.4
33
87
C07AB07
ATC
bisoprolol; oral
1.5
8.3
376
2863
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
4.1
8.3
31
78
H16.0
ICD-10 Finland
Corneal ulcer
2.9
8.3
49
176
QAJ10
NOMESCO Finland
Browlift
14.6
8.2
13
9
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
8.2
81
382
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.1
8.2
91
455
UJF32
NOMESCO Finland
Coloscopy
1.6
8.1
215
1437
G44.0
ICD-10 Finland
Cluster headache syndrome
6.4
8.0
20
32
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
22.2
8.0
11
5
A02BC01
ATC
omeprazole; systemic
1.6
8.0
242
1672
UDC00
NOMESCO Finland
Ear microscopy
2.4
8.0
65
280
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
7.9
324
2405
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
7.9
77
361
R53
ICD-10 Finland
Malaise and fatigue
1.7
7.9
177
1127
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
7.9
61
256
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
7.9
280
2014
N02AA05
ATC
oxycodone; systemic
1.9
7.9
118
661
R01AD12
ATC
fluticasone furoate; nasal
1.6
7.9
250
1750
H53.1
ICD-10 Finland
Subjective visual disturbances
2.5
7.9
61
257
D33.30
ICD-10 Finland
Acoustic neuroma
9.5
7.8
15
16
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.8
300
2198
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.2
7.8
39
126
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
7.7
450
3601
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
45.3
7.7
9
*
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.6
7.7
218
1484
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
18.5
7.6
11
6
R25.2
ICD-10 Finland
Cramp and spasm
3.7
7.6
31
85
N05BA04
ATC
oxazepam; oral
1.6
7.6
216
1469
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
6.2
7.6
19
31
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
5.5
7.6
21
39
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
7.5
549
4591
R50.9
ICD-10 Finland
Fever, unspecified
1.8
7.5
122
701
P01AB01
ATC
metronidazole; oral, rectal
1.5
7.4
346
2637
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
7.4
333
2518
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.4
199
1332
M54.2
ICD-10 Finland
Cervicalgia
2.4
7.4
63
276
R13
ICD-10 Finland
Dysphagia
2.4
7.4
61
266
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.3
7.3
64
287
R52.1
ICD-10 Finland
Chronic intractable pain
8.4
7.3
15
18
M79.7
ICD-10 Finland
Fibromyalgia
3.1
7.3
38
126
G43.9
ICD-10 Finland
Migraine, unspecified
2.5
7.3
55
229
2181
FHL
Root fracture, decompression or coagulation
+∞
7.3
7
*
AAH30
NOMESCO Finland
Thermal destruction of cranial nerve
+∞
7.3
7
*
M54.1
ICD-10 Finland
Radiculopathy
3.1
7.3
37
121
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.6
7.3
50
196
H02.3
ICD-10 Finland
Blepharochalasis
2.4
7.2
60
262
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
3.3
7.2
34
105
H57.1
ICD-10 Finland
Ocular pain
3.3
7.2
34
105
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.4
7.2
59
254
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.3
7.2
62
275
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
7.2
173
1125
M48.0
ICD-10 Finland
Spinal stenosis
2.0
7.1
87
449
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
7.1
340
2598
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.5
7.1
54
226
D07AC01
ATC
betamethasone; topical
1.5
7.1
289
2133
R52.2
ICD-10 Finland
Other chronic pain
3.4
7.1
32
96
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
7.1
61
270
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.4
7.1
24
56
L17
ICPC
Foot/toe symptom/complaint
1.6
7.1
202
1372
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.8
7.0
22
47
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
7.0
485
3989
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
6.9
134
817
M54.6
ICD-10 Finland
Pain in thoracic spine
2.4
6.9
58
255
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
13.9
6.9
11
8
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.3
6.9
58
256
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
6.8
186
1248
G57.6
ICD-10 Finland
Lesion of plantar nerve
8.3
6.8
14
17
R25.3
ICD-10 Finland
Fasciculation
11.0
6.8
12
11
ZXA05
NOMESCO Finland
Left side
1.6
6.8
209
1444
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
6.8
202
1383
WX290
NOMESCO Finland
Other blockade of nerve
1.5
6.8
353
2740
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
4.1
6.7
24
59
M54.3
ICD-10 Finland
Sciatica
2.5
6.7
50
206
R06AX27
ATC
desloratadine; oral
1.5
6.7
228
1615
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.1
6.7
34
112
Z50.1
ICD-10 Finland
Other physical therapy
2.5
6.6
50
208
J01AA02
ATC
doxycycline; systemic
1.5
6.6
692
6130
KMAK
NOMESCO Finland
NA
1.4
6.6
439
3567
C07AA05
ATC
propranolol; systemic
1.6
6.6
176
1173
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.0
6.6
36
125
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
4.4
6.6
22
51
J01CA04
ATC
amoxicillin; systemic
1.5
6.6
710
6325
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
6.5
214
1501
M01AB08
ATC
etodolac; oral
2.1
6.5
68
333
XCK00
NOMESCO Finland
Perimetry
2.2
6.5
61
285
R4120
NOMESCO Finland
Occupational therapy
2.2
6.5
60
277
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
6.5
601
5188
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.5
6.5
49
205
R03AC02
ATC
salbutamol; inhalant
1.4
6.4
449
3675
TCE00
NOMESCO Finland
Therapeutic injection into extraocular muscle
70.3
6.4
7
*
F95.9
ICD-10 Finland
Tic disorder, unspecified
70.3
6.4
7
*
AAH50
NOMESCO Finland
Cranial nerve anastomosis
70.3
6.4
7
*
WX002
NOMESCO Finland
Sedation and analgesia
1.6
6.4
160
1046
Z01.2
ICD-10 Finland
Dental examination
1.4
6.4
335
2595
L03
ICPC
Low back symptom/complaint
1.6
6.4
190
1299
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.2
6.4
63
300
N03AX09
ATC
lamotrigine; oral
2.6
6.4
45
180
E0000UV
ATC
NA
1.4
6.4
330
2552
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
6.4
140
883
R52.9
ICD-10 Finland
Pain, unspecified
2.1
6.4
71
356
N03
ICPC
Pain face
6.6
6.3
15
23
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
6.6
6.3
15
23
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
6.3
71
358
M77.0
ICD-10 Finland
Medial epicondylitis
4.0
6.3
23
58
M50.3
ICD-10 Finland
Other cervical disc degeneration
3.7
6.3
25
68
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
6.3
92
510
TAC00
NOMESCO Finland
Peripheral nerve block
18.1
6.3
9
5
35008
ICD-8 Finland
Facial paralysis, Alia definita
+∞
6.3
6
*
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
+∞
6.3
6
*
G50.9
ICD-10 Finland
Disorder of trigeminal nerve, unspecified
26.9
6.2
8
*
N06AA10
ATC
nortriptyline; systemic
3.8
6.2
24
64
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.8
6.2
24
64
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
2.1
6.2
70
353
M01AH01
ATC
celecoxib; oral (coxibs)
1.6
6.2
146
942
UKC02
NOMESCO Finland
Cystoscopy
1.7
6.2
122
747
M79.1
ICD-10 Finland
Myalgia
1.8
6.1
105
618
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
6.1
212
1508
SPAT1262
SPAT
Handing over of treatment supplies
1.7
6.1
134
849
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.0
466
3871
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
381
2409
1.90
20.95
2.2
2.1
125.4
213.5
u/l
2.08
356
2260
41
88
4.80
18.10
1.0
1.1
—
—
—
0
0
31
53
5.99
17.51
1.0
1.0
1.3
1.1
u/l
0.33
12
30
550
4040
1.74
17.45
6.2
6.4
1.2
1.2
mmol/l
0.23
458
3399
32
58
5.66
17.03
1.2
1.1
31.4
38.9
mg/l
0.52
27
48
622
4830
1.69
15.24
4.5
4.7
6.6
6.6
mmol/l
0.03
590
4487
762
6302
1.73
14.24
4.9
3.8
11.1
11.9
mm/h
0.93
726
5810
55
175
3.26
14.14
1.2
1.3
161.0
2346.6
e6/l
0.74
43
136
55
175
3.26
14.14
1.2
1.2
40.6
11.2
e6/l
0.47
41
131
32
69
4.75
14.06
1.0
1.0
—
—
—
0
0
490
3660
1.63
13.30
5.4
5.8
1.2
1.2
mmol/l
0.43
442
3298
424
3087
1.62
12.58
3.6
3.4
25.3
50.9
ng/l
1.30
272
2060
27
56
4.92
12.42
1.0
1.0
—
—
—
0
0
687
5622
1.62
12.42
5.3
4.2
201.6
3103.6
e6/l
—
9
80
776
6593
1.64
11.58
8.2
7.2
75.2
77.4
u/l
0.95
741
6191
961
8704
2.02
11.13
17.3
12.9
21.0
23.5
mg/l
1.45
776
6783
536
4210
1.55
10.98
4.2
3.5
0.0
0.0
estimate
0.00
99
795
442
3358
1.54
10.35
2.0
1.9
95.8
95.3
pmol/l
0.08
232
1701
536
4249
1.52
10.27
5.6
4.8
0.0
0.0
estimate
0.50
101
803
981
9002
2.08
10.15
18.3
14.8
3.9
4.0
mmol/l
0.47
958
8723
539
4286
1.52
10.13
4.3
3.5
0.0
0.0
estimate
1.08
93
789
787
6809
1.59
9.90
4.3
4.0
14.7
14.8
pmol/l
0.68
726
6193
201
1288
1.69
9.48
3.1
3.4
0.8
0.8
mmol/l
1.16
184
1214
77
360
2.23
9.35
1.6
2.1
38.6
40.2
u/l
0.30
69
316
603
4957
1.50
9.34
10.1
9.0
4.0
4.0
e9/l
0.12
542
4336
453
3516
1.50
9.30
5.2
4.7
36.4
35.7
g/l
2.25
419
3266
249
1694
1.61
9.27
2.5
2.5
4.7
6.3
e6/l
1.33
212
1500
975
8981
1.96
9.15
18.2
14.7
139.7
139.7
mmol/l
0.15
955
8718
541
4368
1.48
9.05
5.9
6.2
10.0
11.1
umol/l
2.23
514
4147
191
1235
1.67
8.65
1.9
2.0
29.2
29.8
s
0.86
184
1198
346
2592
1.49
8.20
2.7
2.4
56.1
57.4
u/l
0.24
322
2387
15
28
5.42
7.74
1.1
1.3
—
—
—
0
0
29
92
3.21
7.58
1.9
1.3
—
—
—
0
0
309
2293
1.49
7.57
3.4
2.9
0.3
0.5
e6/l
1.64
237
1723
247
1757
1.53
7.39
4.6
3.8
1.0
1.0
kg/l
0.54
40
246
162
1044
1.65
7.38
3.9
5.2
1.0
1.0
mmol/l
0.24
149
961
211
1454
1.56
7.28
1.3
1.2
19.1
31.1
iu/ml
1.88
68
479
137
851
1.70
7.17
5.6
9.1
5.1
5.1
kpa
0.06
128
811
101
574
1.84
7.17
1.8
1.6
—
—
—
0
0
137
852
1.70
7.14
5.6
9.1
12.6
12.3
kpa
0.25
128
815
885
8062
1.57
7.04
5.3
4.7
1.8
2.0
mu/l
0.96
811
7402
412
3267
1.42
7.01
4.4
3.7
—
—
—
0
0
122
742
1.73
6.89
2.0
2.1
365.6
377.0
nmol/l
0.28
112
687
135
850
1.67
6.71
5.8
9.1
1.4
1.3
mmol/l
0.09
97
664
297
2240
1.45
6.55
4.7
3.8
0.0
0.0
estimate
0.88
99
779
65
328
2.05
6.55
1.3
1.2
0.2
1.5
u/ml
—
6
21
365
2890
1.40
6.06
3.5
3.4
2.3
2.4
mmol/l
0.90
329
2534
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
40
4.05
5.91
1.1
1.1
—
—
—
0
0
253
1893
1.44
5.73
1.5
1.5
19.0
21.1
nmol/l
1.69
223
1618
196
1397
1.49
5.69
3.1
2.6
1.4
1.3
e6/l
0.05
112
778
10
17
5.93
5.63
1.1
1.3
—
—
—
0
0
88
521
1.75
5.48
1.3
1.2
166.1
217.7
u/ml
0.32
79
476
73
414
1.82
5.26
1.4
1.3
23.3
28.2
iu/l
0.65
62
356
191
1376
1.47
5.24
1.3
1.2
7.4
14.9
u/ml
0.80
77
550
320
2530
1.38
5.21
3.1
3.0
7.7
7.5
mmol/l
0.38
270
2138
428
3545
1.35
5.16
2.5
2.2
76.5
77.5
nmol/l
0.31
397
3186
232
1740
1.43
5.13
1.7
1.6
177419771.7
25802380.7
pmol/l
0.52
186
1434
449
3753
1.34
5.07
3.2
2.7
104.0
119.5
ug/l
0.90
412
3450
17
50
3.44
5.04
2.9
1.9
—
—
—
0
0
11
23
4.82
5.02
1.0
1.1
—
—
—
0
0
864
7981
1.43
4.98
5.9
5.3
39.2
39.4
mmol/mol
0.21
807
7400
469
3957
1.33
4.92
4.4
3.9
—
—
—
0
0
13
32
4.10
4.90
1.1
1.5
—
—
—
0
0
207
1534
1.43
4.88
4.0
3.5
68.8
361.5
ng/l
5.06
136
1152
984
9345
1.66
4.87
12.3
9.8
26.1
25.5
u/l
0.61
946
9016
288
2261
1.37
4.85
2.8
2.9
840.6
1156.4
ng/l
1.67
240
1909
102
652
1.62
4.80
2.6
2.4
4.9
7.1
ug/l
0.92
90
571
11
24
4.62
4.79
1.0
1.1
—
—
—
0
0
267
2076
1.38
4.76
2.3
2.1
2.9
3.0
mg/l
0.26
220
1757
76
451
1.74
4.72
6.4
8.4
24.4
24.6
mmol/l
0.22
70
420
52
278
1.91
4.53
2.1
2.1
6119.6
3223.4
u/l
0.20
19
120
117
784
1.55
4.52
2.1
2.3
42.6
35.9
u/l
0.34
99
660
650
5789
1.31
4.44
3.3
3.0
41.8
46.3
u/l
1.26
616
5403
53
288
1.88
4.40
1.8
1.5
341.4
293.0
mu/l
0.25
53
258
106
703
1.56
4.29
6.4
10.2
125.0
120.1
g/l
1.67
98
679
243
1901
1.36
4.11
1.8
1.6
0.8
1.1
mg/l
2.50
180
1422
177
1319
1.41
4.01
3.4
2.8
3.1
3.0
e6/l
0.06
94
700
16
53
3.05
3.97
1.4
2.4
—
—
—
0
0
48
262
1.87
3.96
1.6
1.7
—
—
—
0
0
337
2783
1.31
3.91
3.0
3.1
31.1
31.9
u/l
0.21
323
2641
262
2088
1.34
3.91
2.5
2.5
1832.1
7180.6
umol/l
2.29
228
1822
27
119
2.30
3.90
1.3
1.6
—
—
—
0
0
308
2514
1.32
3.89
4.1
3.8
4.4
8.4
mg/mmol
2.74
188
1541
197
1507
1.38
3.82
1.5
1.5
—
—
—
0
0
94
627
1.55
3.73
3.0
3.5
81.0
81.2
ng/l
0.01
79
546
43
232
1.89
3.69
1.3
1.3
—
—
—
0
0
33
163
2.06
3.63
4.1
4.3
58.1
57.8
%
0.06
33
163
793
7342
1.31
3.62
20.9
15.9
13.7
13.7
%
0.18
780
7168
12
35
3.46
3.62
1.1
1.1
—
—
—
0
0
9
17
5.33
3.51
1.0
1.2
—
—
—
0
0
164
1234
1.39
3.51
2.1
2.3
13.0
13.3
umol/l
0.22
150
1133
127
916
1.44
3.45
1.8
2.0
—
—
—
0
0
38
203
1.90
3.38
1.2
1.2
8.0
11.3
u/l
0.90
31
167
16
59
2.74
3.33
1.1
1.1
—
—
—
0
0
16
59
2.74
3.33
1.1
1.1
—
—
—
0
0
234
1875
1.32
3.32
1.4
1.2
1.5
1.6
u/ml
0.07
53
507
189
1473
1.34
3.24
1.9
1.7
1116.5
1219.4
nmol/l
0.72
141
1088
16
60
2.69
3.23
1.1
1.1
—
—
—
0
0
16
60
2.69
3.23
1.1
1.1
—
—
—
0
0
16
60
2.69
3.23
1.1
1.1
—
—
—
0
0
900
8526
1.35
3.20
4.7
4.3
5.9
5.9
mmol/l
0.11
829
7767
141
1051
1.39
3.20
2.1
2.3
21.1
23.4
%
1.36
116
895
15
55
2.75
3.16
2.0
1.8
12.2
12.4
%
—
5
23
1012
9801
1.60
3.08
25.2
19.1
252.1
253.6
e9/l
0.34
994
9542
31
160
1.97
3.07
3.9
3.9
4.4
4.2
e9/l
0.16
31
160
114
826
1.43
3.04
1.8
1.8
—
—
—
0
0
1012
9808
1.59
2.98
25.1
19.1
4.5
4.5
e12/l
0.52
995
9523
5
5
10.04
2.98
1.0
1.4
—
—
—
0
0
611
5546
1.24
2.95
3.3
3.0
—
—
—
0
0
166
1288
1.34
2.93
2.0
1.8
—
—
—
0
0
1012
9812
1.58
2.93
25.2
19.2
135.3
135.0
g/l
0.34
1001
9654
148
1129
1.36
2.92
2.0
2.3
2.4
2.3
g/l
1.17
139
1044
8
17
4.73
2.92
1.4
1.8
1059.3
395.1
mu/l
—
8
17
8
17
4.73
2.92
1.4
1.8
75.2
72.5
%
—
8
17
18
77
2.36
2.83
1.4
1.2
1.3
0.9
u/ml
—
9
32
78
537
1.49
2.73
2.1
3.5
4.2
4.5
pmol/l
2.33
71
475
130
984
1.37
2.70
6.8
6.4
—
—
—
0
0
14
55
2.57
2.62
1.1
1.1
—
—
—
0
0
22
107
2.08
2.58
1.1
1.1
—
—
—
0
0
92
662
1.43
2.58
1.9
2.6
75.9
66.9
ml/min/173m2
1.34
40
262
9
25
3.62
2.57
2.4
1.6
—
—
—
0
0
9
25
3.62
2.57
1.0
1.2
—
—
—
0
0
22
108
2.06
2.53
1.2
1.4
0.5
0.6
nmol/l
2.51
22
102
119
899
1.36
2.51
1.7
1.8
—
—
—
0
0
118
891
1.36
2.50
1.8
1.7
—
—
—
0
0
87
624
1.43
2.49
2.9
2.7
66.0
67.0
g/l
0.54
75
569
6
12
5.02
2.40
1.3
1.0
—
—
—
0
0
5
8
6.27
2.37
1.0
1.5
—
—
—
0
0
38
232
1.66
2.26
2.4
2.9
—
—
—
0
0
5
9
5.57
2.21
1.0
1.3
—
—
—
0
0
69
488
1.44
2.16
3.2
3.1
1.6
1.7
mmol/l
0.18
52
362
92
687
1.37
2.12
5.2
7.6
1.3
1.3
mmol/l
0.25
87
654
8
25
3.22
2.09
1.0
1.1
—
—
—
0
0
8
25
3.22
2.09
1.0
1.1
—
—
—
0
0
29
168
1.75
2.09
1.4
1.3
—
—
—
0
0
29
168
1.75
2.09
1.4
1.3
—
—
—
0
0
24
131
1.85
2.09
1.4
1.5
0.4
0.4
nmol/l
0.10
19
106
127
998
1.31
2.08
20.0
24.3
1.4
1.3
inr
0.23
19
126
46
303
1.54
2.03
4.6
7.2
1.6
1.5
%
0.15
40
283
43
279
1.56
2.03
2.3
2.2
—
—
—
0
0
43
279
1.56
2.03
2.3
2.2
7.2
7.3
g/l
0.14
32
209
43
279
1.56
2.03
2.3
2.2
3.5
3.7
g/l
0.54
30
201
36
224
1.63
2.02
1.5
1.2
—
—
—
0
0
8
26
3.09
2.01
1.1
1.1
114.9
110.4
%
—
8
21
71
513
1.41
1.99
3.3
3.1
5.1
5.1
kpa
0.23
66
478
21
112
1.89
1.97
1.2
1.1
—
—
—
0
0
40
258
1.57
1.95
2.1
2.3
3.1
3.1
g/l
0.06
30
204
33
203
1.65
1.94
2.3
2.4
0.0
0.0
g/l
0.00
27
184
188
1567
1.24
1.93
3.3
3.0
2.4
2.4
mmol/l
0.79
167
1386
36
227
1.61
1.92
1.3
1.1
—
—
—
0
0
34
212
1.62
1.90
2.3
2.4
0.0
0.0
g/l
0.00
28
193
5
141
0.35
1.89
1.2
1.5
—
—
—
0
0
47
317
1.50
1.89
1.3
1.4
—
—
—
0
0
109
854
1.31
1.85
4.6
4.3
226.7
243.6
u/l
0.81
102
809
267
2318
1.20
1.83
1.6
1.6
1.4
1.4
mmol/l
0.29
231
1961
5
12
4.18
1.82
1.8
1.2
—
—
—
0
0
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
5
12
4.18
1.82
1.0
1.1
78.2
95.9
%
—
5
12
40
263
1.54
1.81
2.3
2.2
9.3
10.4
g/l
0.84
33
224
13
60
2.18
1.78
1.5
2.4
7.7
0.7
u/field
—
7
24
116
922
1.29
1.77
2.7
2.7
8.4
8.0
umol/l
0.05
102
810
903
8710
1.24
1.75
4.6
4.2
4.7
4.7
mmol/l
0.64
847
8081
32
202
1.60
1.73
2.3
2.4
0.0
0.0
g/l
0.00
27
184
8
30
2.68
1.72
1.1
1.0
—
—
—
0
0
7
24
2.93
1.72
1.0
1.1
—
—
—
0
0
57
408
1.42
1.72
3.1
2.6
0.2
0.2
e6/l
0.14
57
394
5
13
3.86
1.71
1.4
1.2
—
—
—
0
0
38
251
1.53
1.70
2.2
1.5
541.0
181.8
titre
—
5
11
36
238
1.53
1.61
2.3
2.4
0.8
1.1
g/l
0.17
29
207
19
106
1.81
1.59
1.2
1.5
—
—
—
0
0
34
223
1.54
1.58
2.3
2.3
39.0
37.9
g/l
0.47
27
190
79
609
1.32
1.53
2.9
2.9
156.7
211.0
ng/l
0.92
70
562
9
182
0.49
1.51
1.8
1.5
—
—
—
0
0
863
8318
1.19
1.51
15.2
12.0
82.5
81.8
ml/min/173m2
0.40
736
6847
63
471
1.36
1.50
7.7
10.8
93.5
93.7
%
0.06
63
466
196
1685
1.20
1.49
4.3
4.1
23.5
21.2
%
0.98
84
774
12
58
2.08
1.49
1.0
1.1
—
—
—
0
0
18
101
1.80
1.49
1.9
2.5
12.1
27.5
mg/l
—
7
27
9
37
2.44
1.48
1.3
3.2
549.0
1234.9
u/ml
—
9
37
241
2113
1.18
1.47
5.4
4.7
2.8
2.4
ug/l
0.20
220
1890
7
28
2.51
1.45
1.0
1.2
8.3
8.9
ug/l
—
7
28
7
28
2.51
1.45
1.3
1.3
—
—
—
0
0
85
670
1.29
1.42
4.6
7.0
8.5
9.3
mmol/l
0.47
80
635
9
40
2.26
1.40
1.0
1.0
—
—
—
0
0
231
2029
1.18
1.38
2.8
2.3
—
—
—
0
0
893
8652
1.19
1.37
4.5
4.2
1.5
1.5
mmol/l
1.48
838
7971
9
41
2.21
1.37
1.2
1.4
—
—
—
0
0
44
316
1.41
1.35
2.4
1.9
—
—
—
0
0
33
225
1.48
1.32
1.5
1.5
276.6
303.6
ug/g
0.30
15
124
67
517
1.32
1.32
1.9
1.8
—
—
—
0
0
6
24
2.51
1.30
4.7
2.5
—
—
—
0
0
912
8865
1.19
1.28
5.1
4.7
2.8
2.8
mmol/l
0.63
856
8171
8
35
2.30
1.27
1.0
1.0
1732.9
1817.5
miu/ml
—
8
35
27
398
0.67
1.25
1.4
1.5
—
—
—
0
0
36
253
1.44
1.25
1.4
1.7
133.5
0.1
iu/ml
—
9
44
65
505
1.31
1.24
2.2
2.2
10.8
12.6
nmol/l
1.03
55
450
5
19
2.64
1.21
1.2
1.6
—
—
—
0
0
61
476
1.30
1.14
1.6
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
30
2.34
1.12
1.0
1.1
124.0
116.4
%
—
7
30
21
135
1.57
1.12
1.6
1.4
—
—
—
0
0
84
686
1.24
1.10
3.3
3.7
1.2
1.2
mmol/l
0.78
73
586
7
32
2.19
1.08
1.0
1.1
580.1
210.0
iu/ml
—
7
32
27
186
1.46
1.07
2.3
1.7
—
—
—
0
0
862
8374
1.15
1.06
4.1
3.8
1.3
1.3
mmol/l
1.14
805
7674
36
263
1.38
1.05
3.2
1.8
—
—
—
0
0
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
15
91
1.66
1.01
1.3
1.2
—
—
—
0
0
14
84
1.68
0.98
2.9
3.8
—
—
—
0
0
10
169
0.59
0.88
1.6
1.7
—
—
—
0
0
15
95
1.59
0.87
1.6
1.6
61.3
62.5
%
—
8
67
25
178
1.41
0.86
1.6
1.5
14955.3
17723.7
e6/l
0.11
20
137
38
291
1.32
0.85
1.9
1.8
—
—
—
0
0
10
57
1.76
0.83
1.2
1.3
—
—
—
0
0
30
223
1.36
0.82
2.1
1.6
—
—
—
0
0
20
138
1.46
0.82
1.4
1.6
—
—
—
0
0
25
181
1.39
0.80
2.6
1.7
—
—
—
0
0
24
173
1.40
0.79
1.3
1.4
—
—
—
0
0
51
412
1.25
0.78
1.7
1.8
—
—
—
0
0
21
148
1.43
0.78
1.4
1.1
0.2
3.2
u/ml
—
9
59
29
217
1.35
0.77
1.4
1.3
—
—
—
0
0
14
91
1.55
0.75
1.7
1.2
—
—
—
0
0
32
245
1.32
0.74
1.7
1.8
6.6
5.4
iu/l
—
7
85
19
133
1.44
0.74
1.2
1.1
—
—
—
0
0
18
125
1.45
0.73
1.4
1.5
—
—
—
0
0
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
7
39
1.80
0.72
1.3
1.1
—
—
—
0
0
9
56
1.61
0.72
1.2
1.3
—
—
—
0
0
76
648
1.19
0.71
1.2
1.2
67.7
136.4
iu/ml
2.71
27
260
5
27
1.86
0.68
1.2
1.3
—
—
—
0
0
100
876
1.16
0.68
2.9
3.2
—
—
—
0
0
826
8070
1.10
0.68
18.7
14.0
39.6
39.8
%
0.25
588
5934
7
43
1.63
0.67
1.3
1.9
3.7
1.9
u/field
—
7
31
33
259
1.28
0.66
1.2
1.2
—
—
—
0
0
24
315
0.76
0.65
3.8
3.3
43.4
4385.6
u/ml
0.77
18
271
33
260
1.28
0.64
1.2
1.2
—
—
—
0
0
110
975
1.14
0.64
1.7
1.8
1.6
1.4
%
0.85
93
853
47
388
1.22
0.62
3.9
3.0
24.1
24.2
mmol/l
0.11
41
355
28
217
1.30
0.62
1.5
1.2
—
—
—
0
0
21
156
1.35
0.61
1.1
1.2
—
1.9
—
0
15
13
187
0.69
0.61
1.4
1.6
—
—
—
0
0
54
460
1.18
0.54
1.2
1.3
—
—
—
0
0
6
39
1.54
0.53
1.2
1.9
—
—
—
0
0
56
480
1.18
0.53
1.6
1.6
—
—
—
0
0
54
462
1.18
0.52
1.1
1.0
—
—
—
0
0
24
189
1.28
0.50
2.2
2.2
44.2
80.5
ug/min
0.44
11
113
36
298
1.22
0.49
2.0
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
246
1.23
0.46
3.2
2.5
0.3
0.3
u/ml
0.09
20
137
75
840
0.88
0.45
4.4
4.3
3.7
26.3
ug/l
1.51
60
679
5
32
1.57
0.42
2.0
1.2
—
—
—
0
0
5
32
1.57
0.42
2.0
1.2
—
—
—
0
0
17
217
0.78
0.41
1.5
1.4
—
—
—
0
0
17
217
0.78
0.41
1.5
1.4
—
—
—
0
0
17
217
0.78
0.41
1.5
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
17
216
0.78
0.40
1.5
1.4
—
—
—
0
0
17
132
1.29
0.40
1.1
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
0.8
—
0
12
5
36
1.39
0.38
5.8
1.8
—
—
—
0
0
5
36
1.39
0.38
5.8
1.8
—
—
—
0
0
5
36
1.39
0.38
5.8
1.8
—
—
—
0
0
5
36
1.39
0.38
5.8
1.8
—
—
—
0
0
9
67
1.35
0.38
1.0
1.1
—
—
—
0
0
80
725
1.11
0.37
3.4
3.0
1.9
2.0
mmol/l
0.10
64
579
172
1619
1.07
0.36
1.5
1.4
—
—
—
0
0
6
44
1.37
0.34
2.2
1.6
—
—
—
0
0
21
172
1.23
0.34
2.4
2.2
127.6
129.8
g/l
0.13
16
129
6
45
1.34
0.33
8.3
3.5
—
—
—
0
0
6
45
1.34
0.33
2.2
1.6
—
—
—
0
0
15
118
1.28
0.33
1.1
1.0
—
—
—
0
0
19
231
0.82
0.33
1.5
1.5
—
—
—
0
0
31
266
1.17
0.32
1.5
1.3
235.7
237.2
miu/ml
—
10
126
11
83
1.33
0.32
1.3
1.0
0.1
0.3
u/ml
—
6
20
25
211
1.19
0.31
1.5
1.3
—
—
—
0
0
41
362
1.14
0.30
1.5
1.8
2.5
4.6
mg/l
0.68
32
260
21
175
1.20
0.30
2.7
2.8
8.6
8.1
kpa
0.82
21
163
14
111
1.26
0.30
1.6
1.5
—
—
—
0
0
11
84
1.31
0.30
2.1
1.7
—
—
—
0
0
80
738
1.09
0.29
3.4
3.0
6.0
5.8
kpa
0.58
74
713
24
204
1.18
0.28
2.7
1.5
—
—
—
0
0
8
65
1.23
0.27
2.5
1.6
—
—
—
0
0
9
72
1.25
0.25
3.8
1.8
—
—
—
0
0
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
79
848
0.93
0.24
1.9
1.7
—
—
—
0
0
5
39
1.28
0.23
2.0
1.2
—
—
—
0
0
5
39
1.28
0.23
2.0
1.2
—
—
—
0
0
130
1241
1.05
0.20
2.9
2.9
0.7
0.7
ug/l
0.04
83
799
100
1055
0.94
0.20
4.5
4.2
31.1
32.3
%
0.59
74
709
21
183
1.15
0.20
1.8
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
3.5
—
—
—
0
0
9
111
0.81
0.20
6.9
2.1
19.1
40.4
u/ml
—
9
105
6
50
1.20
0.19
1.3
1.2
—
—
—
0
0
6
53
1.13
0.18
1.2
1.1
—
—
—
0
0
11
131
0.84
0.17
1.3
1.2
—
—
—
0
0
5
69
0.72
0.17
1.2
1.6
1.0
1.0
g/l
—
5
69
8
68
1.18
0.16
1.0
1.0
—
—
—
0
0
8
69
1.16
0.16
4.0
1.6
—
—
—
0
0
8
69
1.16
0.16
4.0
1.6
—
—
—
0
0
8
69
1.16
0.16
4.0
1.6
—
—
—
0
0
14
120
1.17
0.16
1.1
1.1
1.6
1.9
u/ml
—
7
56
8
71
1.13
0.16
1.5
2.1
—
—
—
0
0
33
359
0.92
0.15
1.6
1.4
—
—
—
0
0
20
224
0.89
0.15
1.4
1.4
49.0
175.3
pmol/l
1.67
20
219
9
79
1.14
0.15
3.9
1.8
—
—
—
0
0
20
178
1.13
0.15
5.8
3.3
40.0
25.4
mg/l
0.66
11
108
19
169
1.13
0.14
1.3
1.2
—
—
—
0
0
12
103
1.17
0.13
1.2
1.1
—
—
—
0
0
8
99
0.81
0.13
2.4
2.0
13.5
13.1
%
—
8
99
15
132
1.14
0.13
3.4
1.8
—
—
—
0
0
15
169
0.89
0.12
3.9
2.5
17.6
16.3
%
—
9
89
17
152
1.12
0.12
1.1
1.2
25.6
40.4
u/l
0.44
17
127
16
143
1.12
0.11
1.2
1.1
1.4
1.8
u/ml
—
10
36
12
105
1.14
0.11
2.2
1.3
—
—
—
0
0
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
12
106
1.13
0.09
2.2
1.3
—
—
—
0
0
12
106
1.13
0.09
2.2
1.3
—
—
—
0
0
13
116
1.12
0.09
1.9
1.6
—
—
—
0
0
5
48
1.04
0.09
1.0
1.1
7.8
15.2
u/l
—
5
42
6
54
1.11
0.09
2.2
1.5
—
—
—
0
0
6
55
1.09
0.09
1.5
1.7
7.0
7.3
mmol/l
—
6
32
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
12
107
1.12
0.08
1.7
1.6
—
—
—
0
0
7
67
1.05
0.08
1.0
1.1
—
—
—
0
0
7
68
1.03
0.08
1.6
2.1
—
—
—
0
0
25
235
1.07
0.07
5.4
3.6
33.5
79.7
mg/l
0.96
20
183
24
252
0.95
0.05
1.4
1.5
—
—
—
0
0
27
258
1.05
0.04
2.3
2.3
141.4
184.2
%
2.79
27
247
13
139
0.93
0.03
1.3
1.1
1.2
6.6
u/ml
—
5
49
11
103
1.07
0.02
2.3
1.3
—
—
—
0
0
11
103
1.07
0.02
2.3
1.3
—
—
—
0
0
11
103
1.07
0.02
1.1
2.1
3.7
5.1
umol/l
0.80
11
72
11
104
1.06
0.01
2.3
1.3
—
—
—
0
0
15
156
0.96
0.00
5.9
3.5
80.5
2366.3
u/ml
0.78
15
145
34
338
1.01
0.00
3.7
3.1
45.1
46.8
%
0.16
34
332
23
229
1.00
0.00
5.6
3.6
—
1.9
—
0
20
13
127
1.02
0.00
3.5
5.4
358.8
370.1
umol/l
0.16
13
108
24
235
1.02
0.00
5.6
3.6
23.8
47.7
mg/l
1.02
19
184
5
49
1.02
0.00
1.0
1.1
60.4
74.7
u/l
—
5
44
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
18.8
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
0.00
2.9
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
6.9
—
0
7
0
7
0.00
0.00
0.0
1.0
—
38.6
—
0
7
5
55
0.91
0.00
11.0
1.9
—
—
—
0
0
7
70
1.00
0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
7.8
—
0
6
0
7
0.00
0.00
0.0
1.0
—
21.2
—
0
7
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_FACOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_FACOTH | 1.072 [0.96, 1.2] | 0.232 |
| Birth year | 0.993 [0.98, 1.0] | 0.123 |
During the follow-up period (1.1.1998 — 31.12.2019), 600 out of 3574 females with G6_FACOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_FACOTH | 1.074 [0.94, 1.22] | 0.275 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 437 out of 2198 males with G6_FACOTH died.
Mortality risk
Mortality risk for people of age
years, who have G6_FACOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.101% | 0.153% |
| 5 | 0.581% | 1.052% |
| 10 | 1.446% | 2.663% |
| 15 | 2.94% | 5.251% |
| 20 | 5.264% | 8.985% |
Relationships between endpoints
↥Index endpoint: G6_FACOTH – Other facial nerve disorders
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data